Details.
Intravenous drip infusion administered at the clinic over approximately 1 hour. The treatment may be provided alongside an IVF protocol or during a natural cycle. The document describes a first infusion a few days before ovulation or egg collection, a second after a positive pregnancy test, and a third after a viable pregnancy has been confirmed by ultrasound at 6 to 7 weeks of gestation, followed by further immune system assessment. Treatment is prescribed off-label and may be considered for patients with a suggestive history and immune system imbalance. The evidence for efficacy in IVF is stated to be inconclusive. Patients with allergies to soya oil or egg yolk should not use Intralipid.